Assessment of intracranial vessels includes transcranial Doppler (TCD). TCD performance requires intact temporal acoustic windows (TAW). Failure of TAW (TAWF) is present in 8-20% of people. There have been no reports on TAWF in rheumatoid arthritis (RA). Altogether, 62 female RA patients were included. Among them, 20 were MTX-treated and biologic-free, 20 received infliximab, and 22 tocilizumab. The controls included 60 non-RA women. TAWF, temporal bone thickness, and texture were determined by ultrasound and CT. BMD and T-scores of multiple bones were determined by DEXA. Several bone biomarkers were assessed by ELISA. In RA, 54.8% of the patients had TAWF on at least one side. Neither TAW could be identified in 34% of RA subjects. In contrast, only 20.0% of control subjects had TAWF on either or both sides (p < 0.001). In RA vs controls, 53.0 vs 2.9% of subjects exerted the trilayer, Bsandwich-like^structure of TAW (p < 0.001). Finally, in RA vs controls, the mean temporal bone thickness values of the right TAW were 3.58 ± 1.43 vs 2.92 ± 1.22 mm (p = NS), while those of the left TAW were 4.16 ± 1.56 vs 2.90 ± 1.16 mm (p = 0.001). There was close association between TAWF, bone thickness, and texture (p < 0.05). These TAW parameters all correlated with age; however, TAW failure and texture also correlated with serum osteoprotegerin. TAW bone thickness inversely correlated with hip BMD (p < 0.05). TAWF, thicker, and heterogeneous temporal bones were associated with RA. These features have been associated with bone loss and OPG production. Bone loss seen in RA may result in OPG release and stimulation of bone formation around TAW.
Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory rheumatic disease affecting the joints and other organ systems [1] .
Accelerated atherosclerosis and increased stroke morbidity and mortality have been associated with RA [2] [3] [4] ; however, no systematic evaluation of intracranial circulation has yet been performed.
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Intracranial vessels, primarily the middle cerebral arteries (MCA), are assessed by transcranial Doppler (TCD). With this technique, cerebral arteries are studied through relatively thin bone windows [5] . Approximately 8-20% of healthy individuals have inadequate temporal acoustic windows (TAW) [6] [7] [8] . This is also defined as TAW failure (TAWF) [9] . The thickness and texture of temporal bone may also influence TAW detectability [9] . There is an increased prevalence of in TAWF in females and in elderly people [6, 7] . In a stroke study, TCD signals could not be adequately obtained due to TAWF in 34% of patients. TAWF, bone thickness, and inhomogeneous texture correlated with age and with each other [9] .
In stroke patients, TAWF did not correlate with vertebral, femoral, or total bone mineral density (BMD). However, heterogeneous temporal bone texture correlated with lower BMD [9] . We have not found any reports on possible associations between TAWF, temporal bone texture and thickness, and various bone markers.
Here we assessed the availability of TAWs in patients with RA. We used a selected healthy population without any known cardiovascular (CV) risk as control group. We determined TAWF, temporal bone thickness, and texture. As RA has been associated with increased bone turnover and generalized bone loss [10, 11] , which could affect bone deposition around the TAW, we also studied the features of TAW in relation to BMD and bone markers. As the examiner has to examine both left and right cerebral arteries during TCD assessment, it is also important to assess TAW on both sides. Furthermore, there may be anatomical differences between left and right side arteries; therefore, we also wished to compare TAW features on left vs right side. To our knowledge, this is the very first study assessing TAWs, TAWF, and characteristics of the temporal bone in RA.
Patients and methods

Patients and controls
Sixty-two consecutive RA patients were recruited for the study. The major characteristics of the patients are shown in Table 1 . All patients were females and their mean age was 60.7 ± 9.5 (range 27-78) years. Mean disease duration was 11.5 ± 7.6 (range 1-36) years. Altogether, 75% were IgM rheumatoid factor (RF) positive, and 75% were anti-CCP positive. Among these patients, 20 were biologic-free. They had been receiving MTX for a mean 6.8 ± 4.7 (range 1-15) years in a mean dose of 14.1 ± 4.5 (range 5-20) mg per week. Altogether, 42 patients had been receiving biologics for a mean duration of 5.2 ± 1.9 (range 1-8) years. In addition, 32 patients were on low-dose corticosteroids. However, they had been receiving it in a stable dose for at least 6 months.
A cohort of 60 non-RA women was chosen as control group. Their mean age was 56.3 ± 10.9 (range 29-90) years. The existence of TAWF was determined in these subjects. None of these individuals had hypertension and known cardiovascular or cerebrovascular disease. The thickness and bone structure of TAWs were assessed in a subset (n = 35) of this control population. In this subset, the mean age was 53.7 ± 4.0 (range 48-60) years.
The Borsod County Teaching Hospital IRB approved this study (No. 13/2016).
Determination of temporal windows
Before the TCD assessment was carried out by ultrasound (not included in this paper), the ultrasonographer (M.S., a single observer) determined whether the right and left TAW were detectable or not. TAWF was determined in 62 RA patients and 60 control subjects. A TAW score was also established. A score of 0, 1, or 2 indicated TAWF on both sides, either side or none of the sides, respectively. Furthermore, the thickness and structure (condense cortical bone or sandwich-like trilayer) of TAWs were determined by computed tomography (CT) (Somatom Definition AS, 64-slice, Siemens, Germany) in 43 RA patients and 35 healthy controls. The instrument was set to bone window and native images of 2-mm thick slices were evaluated. The thickness of TAW expressed in millimeters was measured at a point 3 cm anterior to the earlobe. With respect to the texture, either a thin temporal bone with a condense, homogenous cortical structure, or a thicker, heterogenous trilayer (cortical-diploe-cortical) pattern could be detected around the TAW [9] . Bone density was not specifically assessed; however, it is always higher in the compact cortical bone, and lower in the thicker trilayer.
Bone densitometry and bone markers
BMD and T-scores of the lumbar L1 and L2-4 vertebrae, femoral neck, and total hip were assessed by DEXA (Hologic 010-0575, Bedford, MA, USA).
Among bone biomarkers, serum calcium and phosphate were determined by routine laboratory methods. Serum osteocalcin (OC; normal < 41 μg/l), β-CrossLaps (CTX; normal < 0.57 μg/l), P1NP (normal < 75 μg/l), 25-hydroxyvitamin D 3 (25-OH-vitD 3 ; normal > 75 nmol/l), parathormon (PTH; normal 1.6-6.9 pmol/l), osteoprotegerin (OPG; median 2.7 pmol/l, normal: to be determined [TBD] locally in the lab), sclerostin (SOST; median 24.1 pmol/l, normal: TBD), and free soluble RANKb ligand (sRANKL; median 0.37 pmol/l in females, normal: TBD) were determined by ELISA (Biomedica, Vienna, Austria). OPG/sRANKL ratios were also calculated.
Statistical analysis
The statistical analysis was processed with IBM SPSS 22 software. The data are expressed as the mean ± SD and frequencies and percentages. Continuous variables were evaluated by paired two-tailed t test and Wilcoxon test. Nominal variables were compared between groups using the chisquared or Fisher's exact test, as appropriate. Simple correlations were determined by Spearman's analysis. Multiple linear regression using the stepwise method was used to determine correlations and independent associations between parameters. TAW parameters were the dependent variables and several other clinical and laboratory parameters were independent variables. The B (+ 95% CI) regression coefficient indicated independent association between the dependent and independent variable during changes. P values < 0.05 were considered significant. The SPSS 22.0 software was used for statistical analysis.
Results
Detectability, texture, and thickness of TAW in RA versus controls
In RA, 34 out of the 62 patients (54.8%) had TAWF on at least one side (neither TAW could be identified in 34% of RA subjects). In contrast, only 20.0% of control subjects had TAWF on either or both sides (p < 0.001) ( Table 2) .
TAW texture could be assessed in 43 RA patients and 35 controls. In control subjects, only one out of 35 subjects exerted the Bsandwich-like^structure on either sides (2.9%). On the other hand, in RA, 53.0% of patients exerted this trilayer texture on at least one side (p < 0.001) ( Table 2) . Thus, while only less than 3% of healthy subjects have sandwich TAW structure, one-third to more than half of RA patients may exert this feature (Table 2) .
Bone thickness around TAW could be assessed also in 43 RA patients and 35 controls. In RA vs controls, the mean temporal bone thickness values of the right TAW were 3.58 ± 1.43 vs 2.92 ± 1.22 mm (p = NS), while those of the left TAW were 4.16 ± 1.56 vs 2.90 ± 1.16 mm (p = 0.001) ( Table 2) .
Correlations between TAW features and disease markers in RA First, the various TAW parameters were correlated with each other (Table 3 ). There have been significant associations between TAWF, thickness, and structure. In the RA cohort (n = 62), the absence of right TAW was significantly associated with increased thickness (R = 0.811, p < 0.001) and the sandwich-like texture of the right TAW (R = 0.712, p < 0.001). Similar observations were made with respect to the left TAWs (thickness R = 0.768, p < 0.01, texture R = 0.791, p < 0.01). The thickness of right and left TAWs also correlated with the heterogeneous texture on the corresponding sides (right R = 0.569, p < 0.01, left R = 0.457, p = 0.02) ( Table 3) . Binary logistic regression analysis was performed in order to determine correlations between TAW characteristics (dependent variables) and other clinical and laboratory parameters (independent variables) ( Tables 4 and 5 ). In the linear regression analysis, TAWF (lower TAW scores) on both sides (p = 0.007) significantly correlated with age. Interestingly, left TAWF was associated with OPG levels (p = 0.012) ( Table 4 ). In addition, this texture on right (p = 0.045) or left (p = 0.016) side exerted significant correlation with OPG (Table 3) . Right (p = 0.025) or left (p = 0.007) TAW bone thickness correlated with age. Finally, TAW thickness on the left side correlated with femoral neck and total hip bone loss (Table 4) .
Multiple regression analysis was performed to determine independent prognostic factors for TAWF in RA. Age (p = 0.026) and serum OPG levels (p = 0.012) were independent predictors of left TAWF. Age was also a predictor of sandwich-like texture of the left TAW (p = 0.007) ( Table 5) .
Discussion
TAW accessibility is essential to perform TCD. Unfortunately, in the general population, TAWF is found in about 8-20% of individuals [6] [7] [8] . In stroke patients, TAWF may be more common (34%) [9] . The texture and the thickness of temporal bone may also be of importance. TAWF has been associated with temporal bone inhomogeneity and increased thickness [9] . The characteristics of TAW have not yet been studied in RA patients so we do not have any reported data for comparison.
Here we performed a study carried out on 62 RA patients in comparison to a population of 60 non-RA individuals undergoing routine TCD screening. In RA patients, TAWF was observed on either or both sides in 34-53% of patients and in 13-20% of controls. The frequency of TAWF was significantly higher compared to controls and was also higher than what was reported by others in the general population [6] .
While only one control subject (3%) had the heterogeneous temporal bone structure, this phenomenon was observed in 53-60% of RA patients. Bone inhomogeneity has also been described in stroke patients [9] .
The temporal bone was also thicker in RA patients (3.6-4.6 mm) compared to controls (2.9 mm). Stroke patients may also exert thicker temporal bones [9] .
We observed significant paired correlations between TAWF, temporal bone heterogeneous texture, and thickness on both sides in RA. Similar observations were reported in patients with acute stroke [9] . By performing linear logistic 
Texture (R) T e x t u r e( L) 0.721 < 0.001 Table 4 Correlations between TAW features and other characteristics in RA patients (n = 62) regression analysis, TAWF, sandwich-like texture and bone thickness all correlated with age. Interestingly, TAWF and the special trilayer texture also correlated with serum OPG levels. OPG was the only bone biomarker that exerted association with TAW characteristics. Finally, left TAW bone thickness inversely correlated with total hip and femoral neck BMD and T-scores indicating, that locally increased TAW thickness may be seen in patients with more pronounced generalized osteoporosis. We also performed multivariate logistic regression analysis. Age was independent prognostic factor for TAWF and sandwich-like texture. Again, serum OPG was an independent predictor of TAWF in RA patients. With age, the temporal bone gets thicker leading to reduced detectability of the foramen. Similar correlations were found in other studies carried out in the general population [6] and in stroke patients [9] . TAW thickness was inversely correlated with hip and femoral neck BMD. RA, especially active disease, has been associated with generalized bone loss [10] [11] [12] [13] primarily due to inflammatory bone resorption [14, 15] . In stroke patients, there was no association between TAWF and BMD; however, temporal bone heterogeneity, similarly to our results, was inversely associated with BMD [9] . OPG is a decoy receptor and inhibitor of RANK-RANKL-mediated inflammatory bone loss [16] . In RA, OPG production may be a counterregulator of bone resorption [16, 17] and both anti-TNF [18] and anti-IL-6 biologics [19] increase circulating OPG levels. In our study, TAWF and heterogeneous texture were correlated with higher OPG levels.
In conclusion, TAWF is more prevalent in RA patients than in the general population. We can hypothesize that as TAWF and TAW thickness have been associated with increased production of OPG and lower hip BMD and T-score, respectively, it is likely that secondary generalized osteopenia/osteoporosis observed in a great proportion of RA patients, especially in those with more severe disease [10, 11] , may induce the counter-regulatory release of OPG. OPG, in turn, may also stimulate bone apposition in the temporal bone surrounding the TAW leading to TAWF, increased thickness and, due to more rapid burn turnover, heterogeneous bone texture [18, 19] . Clinically, the detection of TAW is not only important to understand temporal bone homeostasis that may also reflect systemic bone metabolism, but also to select patients suitable for TCD assessments. More studies to be carried out in large number of patients are necessary to further characterize TAWF, features of the temporal bone and their relation to bone biology. 
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